Caprelsa

­
  • CAPRELSA

Caprelsa

Facts of CAPRELSA (vandetanib) tablets 300mg ?

  • Medicine Name: CAPRELSA
  • Generic Name: Vandetanib
  • Approval Date: Feb 21, 2012
  • Company Name: AstraZeneca Pharmaceuticals LP
  • Available as (Form & Strength): 100 mg and 300mg tablets

Category:

Product Description

What are the indications and usage?

  • CAPRELSA is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
  • Use CAPRELSA in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA.

Reviews

There are no reviews yet.

Be the first to review “Caprelsa”